Global plasma fractionation market size is anticipated to grow at a CAGR of 7.5% during the forecast period of 2021 to 2028. The plasma fractionation market will touch the valuation of around US$ 34 billion by 2028.
This remarkable growth is attributed to plethora of reasons. Increased indications and therapeutic use of plasma-derived proteins in the healthcare sector is one of the key reasons driving the growth of the global plasma fractionation market. In addition to this, considerable increase in the number of older people in all worldwide locations is fueling the growth of the market for plasma fractionation.
Plasma fractionation is the first process for large-scale protein purification, which was developed about 60 years ago by Cohn and co-workers. Currently, therapeutically important proteins are human serum albumin (HSA), immunoglobulin (IG), coagulation factor VIII, and protease inhibitors. Presently, plasma protein fractionation is, by far, the largest segment in the global therapeutic protein manufacture industry. Rising indications and therapeutic usage of plasma-derived proteins is an important factor that is expected to boost the plasma fractionation market during the forecast period.
The report performs segmentation of the global plasma fractionation market on the basis of various key aspects such as application, product type, end-user, and region. In recent period, the market for plasma fractionation is witnessing rising demand avenues from the healthcare sector. Some of the key products with high demand are coagulation factor concentrates, immunoglobulin, protease inhibitors, albumin, and other plasma products. Thus, rising demand for these products will boost the market growth in the upcoming years.
Rising Demand for Plasma Proteins Boosts Market Growth
The global plasma fractionation market is witnessing stupendous growth avenues owing to plethora of reasons. Rising investments in innovation, growing occurrence of various rare diseases, and growing demand for plasma proteins from all across the world are some of the key factors working as a driver for the development of the global plasma fractionation market.
Many enterprises from healthcare sector are growing their efforts on research and development activities. The main motive of these efforts is the development of novel plasma protein therapies and innovative treatment options. All these factors are fueling the growth of the global plasma fractionation market.
Vendors Execute Diverse Strategies to Lead Market
The global plasma fractionation market is fairly fragmented in nature. Owing to presence of many players, the competitive landscape of the market for plasma fractionation is highly intense. Several vendors are executing diverse strategies to maintain the leading position in the global plasma fractionation market. This aside, many enterprises are entering into partnership agreements. These moves are helping them to expand regional presence and gain leading position in the market for plasma fractionation.
Shire plc, CSL Limited, Biotest AG., Sanquin, Baxter International Inc., GRIFOLS, Octapharma, China Biologic Products Holdings, Inc., and Kedrion are some of the key players working in the global plasma fractionation market.
North America Shows Lucrative Avenues for Market Growth
Asia Pacific, North America, Europe, Middle East and Africa, and Latin America are key regions for the global plasma fractionation market. Of them, North America is one of the prominent regions offering lucrative avenues for the market growth. Players are expected to witness stupendous sales opportunities in the forthcoming period. This growth is attributed to high occurrence of various infectious diseases including influenza, cholera, and syphilis in this region. Apart from this, noteworthy number of older population in North America signifies that the plasma fractionation market will grow at a rapid pace during forecast period of 2021 to 2028.
Covid-19 Impact Analysis On Global Plasma Fractionation Market
COVID-19 pandemic has affected every industry worldwide. For instance, after COVID-19 was declared as a pandemic by the WHO, countries worldwide adopted nationwide lockdowns to observe social distancing as a measure to contain the spread. This lead to disruption, limitation, challenges, and changes in each sector of every industry. Similarly, the plasma fractionation industry was also impacted by the pandemic. For instance, the outbreak of COVID-19 pandemic has led to decrease in number of blood donations and plasma collections, which hampers market as it leads to shortage in raw material supply. However, decrease in raw material supply was compensated by fall in demand for plasma derivatives in the starting of nationwide lockdowns, as elective surgical procedures were postponed and availability of treatment for other medical conditions was also hampered. In addition, overall plasma supply in countries is maintained, however, some areas may face shortages. Thus, the viral outbreak had a negative impact on the plasma fractionation market.
The global plasma fractionation market has been segmented based on product type, application, end-user and region. In terms of product type, the global plasma fractionation market has been classified into immunoglobulin, coagulation factor concentrates, albumin, protease inhibitors, and other plasma products. The immunoglobulin segment has been further sub-segmented into intravenous immunoglobulin and subcutaneous immunoglobulin. The coagulation factor concentrates segment factor VIII, factor IX, factor XIII, prothrombin complex concentrate, Von Willebrand factor and fibrinogen concentrates. The market size and forecast for each of these segments have been provided for the period from 2021 to 2028, along with their respective CAGRs for the forecast period from 2021 to 2028, considering 2020 as the base year.
In terms of application, the global plasma fractionation market has been segregated into neurology, immunology, hematology, critical care, pulmonology, and other applications. The market size and forecast for each of these segments have been provided for the period from 2021 to 2028, along with their respective CAGRs for the forecast period from 2021 to 2028, considering 2020 as the base year.
In terms of end-user, the global market has been classified into hospitals and clinics, clinical research laboratories, and academic institutes. The segments have been analyzed based on health care infrastructure, government investment, and economic development in the regions. The market size and forecast for each of these segments have been provided for the period from 2021 to 2028, along with their respective CAGRs for the forecast period from 2021 to 2028, considering 2020 as the base year.
Major players operating in the global plasma fractionation market include CSL Limited, Shire plc, Sanquin, Biotest AG., GRIFOLS, Baxter International Inc., Kedrion, Octapharma and China Biologic Products Holdings, Inc. These players adopt organic and in-organic growth strategies in order to expand product offerings, strengthen geographical reach, increase customer base, and capture market share.
By End User
The Plasma fractionation market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Plasma fractionation market for the base year 2020 and the forecast between 2021 and 2028. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Plasma fractionation market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Plasma fractionation market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Plasma fractionation market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Plasma fractionation capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Plasma fractionation by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Plasma fractionation market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2028. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Plasma fractionation market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Plasma fractionation market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Plasma fractionation industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
Plasma fractionation market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Plasma fractionation market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Plasma fractionation market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Plasma fractionation market. These factors have benefited the growth of the global market for Plasma fractionation. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Plasma fractionation. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Plasma fractionation are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
Cancer Immunotherapy Market (By Product: Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies and Cancer Vaccines; By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head and Neck Cancer, Ovarian Cancer, Pancreatic Cancer) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Women’s Health App Market (By Type: Fitness & Nutrition, Menstrual Health, Pregnancy Tracking & Postpartum Care, Menopause, Disease Management) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Biopharmaceutical Third Party Logistics Market (By Supply Chain: Cold Chain, Non-cold Chain; By Service Type: Transportation, Warehousing and Storage) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Traumatic Brain Injury Assessment & Management Devices Market (By Device: Imaging Devices, Monitoring Devices; By Technique: Intracranial Pressure (ICP) Monitoring, Partial Pressure of Oxygen in Brain Tissue (pBrO2); By End-use: Hospitals, Diagnostic Centers, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Magnetic Resonance Imaging Market (By Architecture: Closed System, Open System; By Field Strength: Low Field Strength, Mid Field Strength, High Field Strength; By Application: Brain and neurological, Spine and musculoskeletal, Vascular, Abdominal, Cardiac, Breast; By End-use: Hospitals, Imaging Centers, Ambulatory Surgical Centers) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...